159 related articles for article (PubMed ID: 9121586)
1. Release of gelatinase A during platelet activation mediates aggregation.
Sawicki G; Salas E; Murat J; Miszta-Lane H; Radomski MW
Nature; 1997 Apr; 386(6625):616-9. PubMed ID: 9121586
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.
Bazou D; Santos-Martinez MJ; Medina C; Radomski MW
Br J Pharmacol; 2011 Apr; 162(7):1577-89. PubMed ID: 21182493
[TBL] [Abstract][Full Text] [Related]
4. Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin.
Falcinelli E; Giannini S; Boschetti E; Gresele P
Br J Haematol; 2007 Jul; 138(2):221-30. PubMed ID: 17593030
[TBL] [Abstract][Full Text] [Related]
5. Cytoskeletal changes in platelets induced by thrombin and phorbol myristate acetate (PMA).
Chen R; Liang N
Cell Biol Int; 1998; 22(6):429-35. PubMed ID: 10328851
[TBL] [Abstract][Full Text] [Related]
6. Diacylglycerol overcomes aspirin inhibition of platelets: evidence for a necessary role for diacylglycerol accumulation in platelet activation.
Werner MH; Senzel L; Bielawska A; Khan W; Hannun YA
Mol Pharmacol; 1991 Apr; 39(4):547-56. PubMed ID: 2017154
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2.
Fernandez-Patron C; Martinez-Cuesta MA; Salas E; Sawicki G; Wozniak M; Radomski MW; Davidge ST
Thromb Haemost; 1999 Dec; 82(6):1730-5. PubMed ID: 10613662
[TBL] [Abstract][Full Text] [Related]
8. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
9. Localization and translocation of MMP-2 during aggregation of human platelets.
Sawicki G; Sanders EJ; Salas E; Wozniak M; Rodrigo J; Radomski MW
Thromb Haemost; 1998 Nov; 80(5):836-9. PubMed ID: 9843180
[TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
Carter AJ; Heptinstall S
Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
[TBL] [Abstract][Full Text] [Related]
11. Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
Judge HM; Buckland RJ; Holgate CE; Storey RF
Platelets; 2005 Nov; 16(7):398-407. PubMed ID: 16236601
[TBL] [Abstract][Full Text] [Related]
12. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
Salvemini D; de Nucci G; Vane JR
Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
[TBL] [Abstract][Full Text] [Related]
13. The P2 receptors in platelet function.
Hechler B; Cattaneo M; Gachet C
Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide.
Martinez A; Salas E; Radomski A; Radomski MW
Med Sci Monit; 2001; 7(4):646-51. PubMed ID: 11433190
[TBL] [Abstract][Full Text] [Related]
15. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
Lockhart LK; McNicol A
J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
[TBL] [Abstract][Full Text] [Related]
16. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
17. Aspirin resistance.
Tantry US; Mahla E; Gurbel PA
Prog Cardiovasc Dis; 2009; 52(2):141-52. PubMed ID: 19732606
[No Abstract] [Full Text] [Related]
18. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
Winocour PD; Kinlough-Rathbone RL; Mustard JF
J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
[TBL] [Abstract][Full Text] [Related]
19. Laboratory detection of 'aspirin resistance': what test should we use (if any)?
Cattaneo M
Eur Heart J; 2007 Jul; 28(14):1673-5. PubMed ID: 17586540
[No Abstract] [Full Text] [Related]
20. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets.
Minuz P; Fumagalli L; Gaino S; Tommasoli RM; Degan M; Cavallini C; Lecchi A; Cattaneo M; Lechi Santonastaso C; Berton G
Biochem J; 2006 Nov; 400(1):127-34. PubMed ID: 16859489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]